Skip to main content
SpringerLink
Log in

NSAIDs and Increased Blood Pressure

What is the Clinical Significance?

  • Leading Article
  • Published:
Drug Safety Aims and scope Submit manuscript

Summary

Several randomised studies have demonstrated that various nonsteroidal antiinflammatory drugs (NSAIDs) elevate blood pressure in normotensive and hypertensive individuals; however, these data have been contradicted by numerous negative studies.

Two meta-analyses have demonstrated that, after pooling data drawn from published reports of randomised trials of younger adults, NSAID use produces a clinically significant increment in mean blood pressure of 5mm Hg, most marked in patients with controlled hypertension. Stratification by NSAID type revealed that piroxicam, naproxen and indomethacin had the greatest, and sulindac the smallest, pressor effect. These data were supported by 2 large community studies involving elderly patients. Recent NSAID users had a 1.7-fold higher risk of requiring the initiation of antihypertensive therapy compared with nonusers; NSAID users also had a 40% increased risk of receiving a diagnosis of hypertension compared with nonusers.

It is vital to determine the nature of the association in the elderly, 12 to 15% of whom are concurrently receiving an NSAID and an antihypertensive agent. Importantly, a 5 to 6mm Hg increase in diastolic blood pressure maintained over a few years may be associated with a 67% increase in total stroke risk and a 15% increase in coronary heart disease events.

While the mechanism(s) remain speculative, salt and water retention through several factors operating in parallel, coupled with increased total peripheral vascular resistance, via increased renal endothelin-1 synthesis, are potentially important.

Clinicians should strive to avoid excessive use of NSAID treatment and consider well-tolerated therapeutic alternatives, including simple analgesics and physical therapy. For patients who require concomitant NSAID and antihypertensive treatment, physicians should be aware that indomethacin, naproxen and piroxicam may be associated with a greater pressor effect than many other NSAIDs, and that antagonism of β-blockers may be greater than that of vasodilators (including ACE inhibitors and calcium antagonists) and diuretics. Finally, the progress of each patient should be monitored by careful blood pressure measurement, particularly during the period of initiation of NSAID therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on detection, evaluation and treatment of high blood pressure. Arch Intern Med 1993; 153: 154–83

    Google Scholar 

  2. Annual Report of the Department of Community Services & Health 1988/89, Statistical Supplement. Canberra, Australian Government Publishing Service 1989: 48

  3. Baum C, Kennedy DL, Forbes MB. Utilization of nonsteroidal antiinflammatory drugs. Arthritis Rheum 1985; 28: 686–92

    PubMed  CAS  Google Scholar 

  4. Committee on Safety of Medicines. CSM update. Non-steroidal anti-inflammatory drugs and serious gastrointestinal reaction —1. BMJ 1986; 292: 614

    Google Scholar 

  5. Griffin JP. Survey of the spontaneous adverse drug reaction reporting schemes in fifteen countries. Br J Clin Pharmacol 1986; 22: 83S–100S

    PubMed  Google Scholar 

  6. O’Brien B. Patterns of European diagnoses and prescribing. London: Office of Health Economics, 1984

    Google Scholar 

  7. Houston MC, Weir M, Gray J, et al. The effects of nonsteroidal anti-inflammatory drugs on blood pressures of patients with hypertension controlled by verapamil. Arch Intern Med 1995; 155: 1049–54

    PubMed  CAS  Google Scholar 

  8. Johnson AG, Simons LA, Simons J, et al. Non-steroidal antiinflammatory drugs and hypertension in the elderly: a community-based cross-sectional study. Br J Clin Pharmacol 1993; 35: 455–9

    PubMed  CAS  Google Scholar 

  9. Davidson RA, Hale WE, Moore MT, et al. Incidence of hypertension in an ambulatory elderly population. J Am Geriatr Soc 1989; 307: 861–6

    Google Scholar 

  10. Sanders LR. Exercise-induced acute renal failure associated with ibuprofen, hydrochlorothiazide and triamterene. J Am Soc Nephrol 1995; 5: 2020–3

    PubMed  CAS  Google Scholar 

  11. Houston MC. Nonsteroidal anti-inflammatory drugs and anti-hypertensives. Am J Med 1991; 90: 42S–7S

    PubMed  CAS  Google Scholar 

  12. Curb JD, Borhani NO, Schnaper H, et al. Detection and treatment of hypertension in older individuals. Am J Epidemiol 1985; 121: 371–6

    PubMed  CAS  Google Scholar 

  13. Cinquegrani MP, Liang C. Indomethacin attenuates the hypotensive action of hydralazine. Clin Pharmacol Ther 1986; 39: 564–70

    PubMed  CAS  Google Scholar 

  14. Sommers De K, van Wyk M, Snyman JR. The countering of diazoxide-induced vasodilation by tenoxicam in normal volunteers. Eur J Clin Pharmacol 1994; 46: 569–71

    PubMed  CAS  Google Scholar 

  15. Cowley AJ, Stainer K, Rowley JM, et al. Effect of aspirin and indomethacin on exercise-induced changes in blood pressure and limb blood flow in normal volunteers. Cardiovasc Res 1985; 19: 177–80

    PubMed  CAS  Google Scholar 

  16. Hardy BG, Bartle WR, Myers M, et al. Effect of indomethacin on the pharmacokinetics and pharmacodynamics of felodipine. Br J Clin Pharmacol 1988; 26: 557–62

    PubMed  CAS  Google Scholar 

  17. Johnson AG, Nguyen TV, Owe-Young R, et al. Potential mechanisms by which nonsteroidal anti-inflammatory drugs elevate blood pressure: the role of endothelin-1. J Hum Hypertens 1996; 10: 257–61

    PubMed  CAS  Google Scholar 

  18. Mookerjee BK, Patak RV, Bentzel CJ, et al. Indomethacin antagonism of the effects of furosemide in normal and hypertensive man [abstract]. Kidney Int 1975; 8: 441

    Google Scholar 

  19. Staessen J, Fagard R, Lijnen P, et al. Effects of prostaglandin synthesis inhibition on blood pressure and humoral factors in exercising, sodium-deplete normal man. J Hypertens 1983; 1: 123–30

    PubMed  CAS  Google Scholar 

  20. Staessen J, Cattaert A, Fagard R, et al. Hemodynamic and humoral effects of prostaglandin inhibition in exercising humans. J Appl Physiol 1984; 56: 39–45

    PubMed  CAS  Google Scholar 

  21. Walter E, Kaufmann W, Oster P. Does chronic aspirin treatment increase blood pressure in man? Klin Wochenschr 1981; 59: 297–9

    PubMed  CAS  Google Scholar 

  22. Beckmann ML, Gerber JG, Byyny RL, et al. Propranolol increases prostacyclin synthesis in patients with essential hypertension. Hypertension 1988; 12: 582–8

    PubMed  CAS  Google Scholar 

  23. Gerber JG, LoVerde M, Byyny RL, et al. The antihypertensive efficacy of hydrochlorothiazide is not prostacyclin dependent. Clin Pharmacol Ther 1990; 48: 424–30

    PubMed  CAS  Google Scholar 

  24. Lewis RV, McLay J, Maclean D, et al. The effects of indomethacin and sulindac upon the blood pressures of individuals with untreated labile or mild hypertension. J Hum Hypertens 1989; 3: 233–7

    PubMed  CAS  Google Scholar 

  25. Takeuchi K, Abe K, Yasujima M, et al. No adverse effect of non-steroidal anti-inflammatory drugs, sulindac and diclofenac sodium, on blood pressure control with a calcium antagonist, nifedipine, in elderly hypertensive patients. Tohoku J Exp Med 1991; 165: 201–8

    PubMed  CAS  Google Scholar 

  26. Reimann IW, Ratge D, Wisser H, et al. Are prostaglandins involved in the antihypertensive effect of dihydralazine? Clin Sci 1981; 61: 319S–21S

    PubMed  CAS  Google Scholar 

  27. Webster J, Petrie JC, McLean I, et al. Flurbiprofen interaction with single doses of atenolol and propranolol. Br J Clin Pharmacol 1984; 18: 861–6

    PubMed  CAS  Google Scholar 

  28. Abbott EC, Daniel J, Watkins J, et al. The effects of indomethacin on blood pressure in treated primary hypertension [abstract]. Clin Res 1978; 26: 834A

    Google Scholar 

  29. Baez MA, Alvarez CR, Weidler DJ. Effects of the nonsteroidal anti-inflammatory drugs, piroxicam or sulindac, on the antihypertensive actions of propranolol and verapamil. J Hypertens 1987; 5 Suppl. 5: S563–6

    CAS  Google Scholar 

  30. Chalmers JP, West MJ, Wing LMH, et al. Effects of indomethacin, sulindac, naproxen, aspirin and paracetamol in treated hypertensive patients. Clin Exp Hypertens 1984; A6(6): 1077–93

    Google Scholar 

  31. Harvey PJ, Wing LM, Beilby J, et al. Effect of indomethacin on blood pressure control during treatment with nitrendipine. Blood Press 1995; 4: 307–12

    PubMed  CAS  Google Scholar 

  32. Sacks HS, Berrier J, Reitman D, et al. Meta-analysis of randomized, controlled trials. N Engl J Med 1987; 316: 450–5

    PubMed  CAS  Google Scholar 

  33. Kirch W, Stroemer K, Hoogkamer JF, et al. The influence of prostaglandin inhibition by indomethacin on blood pressure and renal function in hypertensive patients treated with cilazapril. Br J Clin Pharmacol 1989; 27: 297S–301S

    PubMed  Google Scholar 

  34. Mills EH, Whitworth JA, Andrews J, et al. Nonsteroidal antiinflammatory drugs and blood pressure. Aust N Z J Med 1982; 12: 478–82

    PubMed  CAS  Google Scholar 

  35. Puddey IB, Beilin LJ, Vandongen R, et al. Differential effects of sulindac and indomethacin on blood pressure in treated essential hypertensive subjects. Clin Sci 1985; 69: 327–6

    PubMed  CAS  Google Scholar 

  36. Pugliese F, Simonetri BM, Cinotti CA, et al. Differential interaction of piroxicam and sulindac with the antihypertensive effect of propranolol [abstract]. Eur J Clin Invest 1984; 14: 54

    Google Scholar 

  37. Quilley J, Duchin KL, Hudes EM, et al. The antihypertensive effect of captopril in essential hypertension: relationship to prostaglandins and the kallikrein-kinin system. J Hypertens 1987; 5: 121–8

    PubMed  CAS  Google Scholar 

  38. Radack KL, Deck CC, Bloomfield SS. Ibuprofen interferes with the efficacy of antihypertensive drugs. A randomized, double-blind, placebo-controlled trial of ibuprofen compared with acetaminophen. Ann Intern Med 1987; 107: 628–35

    PubMed  CAS  Google Scholar 

  39. Salvetti A, Pedrinelli R, Magagna A, et al. Differential effects of selective and non-selective prostaglandin-synthesis inhibition on the pharmacological responses to captopril in patients with essential hypertension. Clin Sci 1982; 63: 261S–3S

    Google Scholar 

  40. Salvetti A, Pedrinelli R, Magagna A, et al. The influence of indomethacin on some pharmacological actions of atenolol. In: Dunn MJ, Patrono C, Cinotto GA, editors. Prostaglandins and the kidney. New York: Plenum Medical Book Company; 1983: 287–95

    Google Scholar 

  41. Salvetti A, Abdel-Haq B, Magagna A, et al. Indomethacin reduces the antihypertensive action of enalapril. Clin Exp Hypertens 1987; A9(2): 559–67

    CAS  Google Scholar 

  42. Smith MD, Kupa A, Weatherall M, et al. The effect of tiaprofenic acid on blood pressure control in treated hypertensive patients. Curr Med Res Opin 1985; 9: 388–93

    PubMed  CAS  Google Scholar 

  43. Watkins T, Abbott EC, Hensby CN, et al. Attenuation of hypertensive effect of propranolol and thiazide diuretics by indomethacin. BMJ 1980; 281: 702–5

    PubMed  CAS  Google Scholar 

  44. Wing LMH, Bune AJC, Chalmers JC, et al. The effects of indomethacin in treated hypertensive patients. Clin Exp Pharmacol Physiol 1981; 8: 537–41

    PubMed  CAS  Google Scholar 

  45. Wong DG, Spence JD, Lamki L, et al. Effect of nonsteroidal anti-inflammatory drugs on control of hypertension by beta-blockers and diuretics. Lancet 1986; I: 997–1001

    Google Scholar 

  46. Cinquegrani MP, Liang C. Antihypertensive effects of pinacidil in patients with and without indomethacin pretreatment. Clin Exp Hypertens 1988; A10(3): 411–31

    CAS  Google Scholar 

  47. Cusson JR, Du Souich P, Le Morvan P, et al. Effect of ketoprofen on blood pressure, endocrine and renal responses to chronic dosing with captopril in patients with essential hypertension. Blood Press 1992; 1: 162–7

    PubMed  CAS  Google Scholar 

  48. Davies JG, Rawlins DC, Busson M. Effect of ibuprofen on blood pressure control by propranolol and bendrofluazide. J Int Med Res 1988; 16: 173–81

    PubMed  CAS  Google Scholar 

  49. Gullner H-G, Gill JR, Bartter FC, et al. The role of the prostaglandin system in the regulation of renal function in normal women. Am J Med 1980; 69: 718–24

    PubMed  CAS  Google Scholar 

  50. Halabi A, Linde M, Zeidler H, et al. Double-blind study on the interaction of oxaprozin with metoprolol in hypertensives. Cardiovasc Drugs Ther 1989; 3: 441–3

    PubMed  CAS  Google Scholar 

  51. Hartmann D, Stief G, Lingenfelder M, et al. Study on the possible interaction between tenoxicam and atenolol in hypertensive patients. Arzneim Forsch 1995; 45: 494–8

    CAS  Google Scholar 

  52. Hollifield JW. Failure of aspirin to antagonise the antihypertensive effect of spironolactone in low-renin hypertension. South Med J 1976; 69: 1034–6

    PubMed  CAS  Google Scholar 

  53. Jackson SH, Pickles H. Indomethacin does not attenuate the effects of hydralazine in normal subjects. Eur J Clin Pharmacol 1983; 25: 303–5

    PubMed  CAS  Google Scholar 

  54. Klassen DK, Jane LH, Young DY, et al. Assessment of blood pressure during naproxen therapy in hypertensive patients treated with nicardipine. Am J Hypertens 1995; 8: 146–53

    PubMed  CAS  Google Scholar 

  55. McKenney JM, Wright JT, Goodman RP, et al. Effect of high-dose ibuprofen on 24-hour blood pressure in healthy women. DICP Ann Pharmacother 1987; 21: 517–20

    CAS  Google Scholar 

  56. Oparil S, Horton R, Wilkins LH, et al. Antihypertensive effect of enalapril in essential hypertension: role of prostacyclin. Am J Med Sci 1987; 294: 395–402

    PubMed  CAS  Google Scholar 

  57. Overlack A, Adamczak M, Bachmann W, et al. For the Perindopril Therapeutic Safety Collaborative Research Group. ACE-inhibition with perindopril in essential hypertensive patients with concomitant diseases. Am J Med 1994; 97: 126–34

    PubMed  CAS  Google Scholar 

  58. Pedrinelli R, Magagna A, Salvetti A. The effect of oxprenolol and indomethacin on renin and aldosterone of normal subjects during low sodium diet. Eur J Clin Invest 1982; 12: 107–1

    PubMed  CAS  Google Scholar 

  59. Reuse C, Leeman M, Degaute J, et al. Preserved renal perfusion during beta blockade by tertatolol with and without cyclooxygenase inhibition in normal humans. J Clin Pharmacol 1988; 28: 312–16

    PubMed  CAS  Google Scholar 

  60. Roberts DG, Gerber JG, Barnes JS, et al. Sulindac is not renal sparing in man. Clin Pharmacol Ther 1985; 38: 258–65

    PubMed  CAS  Google Scholar 

  61. Shaw W, Shapiro D, Antonello J, et al. Indomethacin does not blunt the antihypertensive effect of lisinopril [abstract]. Clin Pharmacol Ther 1987; 41: 219

    Google Scholar 

  62. Stokes GS, Brooks PM, Johnston HJ, et al. The effects of sulindac and diclofenac in essential hypertension controlled by treatment with a beta blocker and/or diuretic. Clin Exp Hypertens 1991; A13(6): 1169–78

    CAS  Google Scholar 

  63. Sugimoto K, Fujimura A, Kumagai Y, et al. Influence of indomethacin on a reduction in forearm blood flow induced by propranolol in healthy subjects. J Clin Pharmacol 1989; 29: 307–10

    PubMed  CAS  Google Scholar 

  64. Takeuchi K, Abe K, Yasujima M, et al. No adverse effect of non-steroidal anti-inflammatory drugs, sulindac and diclofenac sodium, on blood pressure control with a calcium antagonist, nifedipine, in elderly hypertensive patients. Tohoku J Exp Med 1991; 165: 201–8

    PubMed  CAS  Google Scholar 

  65. Weiss Y, Chenard A, De Kermadec JM, et al. Maintenance of blood pressure control in elderly hypertensives on ketoprofen. Scand J Rheumatol 1991; Suppl. 91: 37–44

    Google Scholar 

  66. Wright JT, McKenney JM, Lehany A, et al. The effect of high-dose short-term ibuprofen on antihypertensive control with hydrochlorothiazide. Clin Pharmacol Ther 1989; 46: 440–4

    PubMed  CAS  Google Scholar 

  67. Abate MA, Layne RD, Neely JL, et al. Effect of naproxen and sulindac on blood pressure response to atenolol. DICP Ann Pharmacother 1990; 24: 810–13

    CAS  Google Scholar 

  68. Abdel-Haq B, Magagna A, Favilla S, et al. The interference of indomethacin and of imidazole salicylate on blood pressure control of essential hypertensive patients treated with atenolol. Preliminary report. Int J Clin Pharmacol Ther Toxicol 1987; 25: 598–600

    PubMed  CAS  Google Scholar 

  69. Alvarez CR, Baez MA, Weidler DJ. Effect of sulindac and piroxicam administration on the antihypertensive effect of propranolol [abstract]. J Clin Pharmacol 1986; 26: 544

    Google Scholar 

  70. Klassen DK, Goodfriend TL, Schuna AA, et al. Assessment of blood pressure during treatment with naproxen or ibuprofen in hypertensive patients treated with hydrochlorothiazide. J Clin Pharmacol 1993; 33: 971–8

    PubMed  CAS  Google Scholar 

  71. Koopmans PP, Thien T, Gribnau FW. Influence of nonsteroidal anti-inflammatory drugs on diuretic treatment of mild to moderate essential hypertension. BMJ 1984; 289: 1492–4

    PubMed  CAS  Google Scholar 

  72. Koopmans PP, Kateman WG, Tan Y, et al. Effects of indomethacin and sulindac on hydrochlorothiazide kinetics. Clin Pharmacol Ther 1985; 37: 625–8

    PubMed  CAS  Google Scholar 

  73. Koopmans PP, Thien T, Thomas CM, et al. Do indomethacin and sulindac antagonise the antihypertensive effect of hydrochlorothiazide? [abstract]. Pharm Week Sci 1985; 7: 87

    Google Scholar 

  74. Koopmans PP, Thien TH, Thomas CM, et al. The effects of sulindac and indomethacin on the antihypertensive and diuretic action of hydrochlorothiazide in patients with mild to moderate essential hypertension. Br J Clin Pharmacol 1986; 21: 417–23

    PubMed  CAS  Google Scholar 

  75. Koopmans PP, Thien T, Gribnau FW. The influence of ibuprofen, diclofenac and sulindac on the blood pressure lowering effect of hydrochlorothiazide. Eur J Clin Pharmacol 1987; 31: 553–7

    PubMed  CAS  Google Scholar 

  76. Lewis RV, Toner JM, Jackson PR, et al. Effects of indomethacin and sulindac on blood pressure of hypertensive patients. BMJ 1986; 292: 934–5

    PubMed  CAS  Google Scholar 

  77. Lewis RV, McLay J, Maclean D, et al. The effects of indomethacin and sulindac upon the blood pressures of individuals with untreated labile or mild hypertension. J Hum Hypertens 1989; 3: 233–7

    PubMed  CAS  Google Scholar 

  78. McMahon FG, Jain AK, Vargas R, et al. Does sulindac attenuate pressure control among hypertensives? Curr Ther Res 1989; 45: 143–51

    Google Scholar 

  79. Salvetti A, Pedrinelli R, Alberici P, et al. The influence of indomethacin and sulindac on some pharmacological actions of atenolol in hypertensive patients. Br J Clin Pharmacol 1984; 17: 108S–11S

    PubMed  Google Scholar 

  80. Steiness E, Waldorff S. Different interactions of indomethacin and sulindac with thiazides in hypertension. BMJ 1982; 285: 1702–3

    PubMed  CAS  Google Scholar 

  81. Trimarco B, De Simone A, Cuocolo A, et al. Role of prostaglandins in the renal handling of a salt load in essential hypertension. Am J Cardiol 1985; 55: 116–21

    PubMed  CAS  Google Scholar 

  82. Polonia J, Boaventura I, Gama G, et al. Influence of non-steroidal anti-inflammatory drugs on renal function and 24h ambulatory blood pressure-reducing effects of enalapril and nifedipine gastrointestinal therapeutic system in hypertensive patients. J Hypertens 1995; 13: 925–31

    PubMed  CAS  Google Scholar 

  83. Johnson AG, Nguyen TV, Day RO. Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med 1994; 121: 289–300

    PubMed  CAS  Google Scholar 

  84. Pope JE, Anderson JJ, Felson DT. A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure. Arch Intern Med 1993; 153: 477–84

    PubMed  CAS  Google Scholar 

  85. Walt R, Katschinski B, Logan R, et al. Rising frequency of ulcer perforation in elderly people in the United Kingdom. Lancet 1986; I: 489–92

    Google Scholar 

  86. Gurwitz JH, Avorn J, Bohn RL, et al. Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapy. JAMA 1994; 272: 781–6

    PubMed  CAS  Google Scholar 

  87. Final Report of the Subcommittee on Definition and Prevalence of the 1984 Joint National Committee. Hypertension prevalence and the status of awareness, treatment and control in the United States. Hypertension 1985; 7: 457–68

    Google Scholar 

  88. Kannel WB, Wolf PA, Verter J, et al. Epidemiologic assessment of the role of blood pressure in stroke. The Framingham Study. JAMA 1970; 214: 301–10

    PubMed  CAS  Google Scholar 

  89. Shurtleff D. Some characteristics related to the incidence of cardiovascular disease and death: Framingham Study, 18-year follow-up. In: Kannel WB, Gordon T, editors. The Framingham Study: an epidemiological investigation of cardiovascular disease. Washington, DC: US Department of Health, Education and Welfare, publication no. (NIH) 74–599; 1974, section 30

    Google Scholar 

  90. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the pooling project. The pooling project research group. J Chron Dis 1978; 31: 201–306

    Google Scholar 

  91. Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the hypertension detection and follow-up program. 1. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 1979; 242: 2562–71

    Google Scholar 

  92. Collins R, Peto R, MacMahon S, et al. Epidemiology. Blood pressure, stroke and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 1990; 335: 827–38

    PubMed  CAS  Google Scholar 

  93. MacMahon S, Peto R, Cutler J, et al. Epidemiology. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765–4

    PubMed  CAS  Google Scholar 

  94. Drayer JI, Weber MA, Sealey JE, et al. Low and high renin essential hypertension: a comparison of clinical and biochemical characteristics. Am J Med Sci 1981; 281: 135–42

    PubMed  CAS  Google Scholar 

  95. Ferri C, Bellini C, Piccoli A, et al. Enhanced blood pressure response to cyclooxygenase inhibition in salt-sensitive human essential hypertension. Hypertens 1993; 21: 875–81

    CAS  Google Scholar 

  96. Meade EA, Smith WL, DeWitt DL. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isoenzymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem 1993; 268: 6610–4

    PubMed  CAS  Google Scholar 

  97. Simon LS. Actions and toxicity of nonsteroidal anti-inflammatory drugs. Curr Opin Rheumatol 1995; 7: 159–66

    PubMed  CAS  Google Scholar 

  98. DeWitt DL, Meade EA, Smith WL. PGH synthase iosenzyme selectivity: the potential for safer nonsteroidal antiinflammatory drugs. Am J Med 1993; 95 Suppl. 2A: 40S–4S

    Google Scholar 

  99. Mitchell JA, Akarasereenont P, Thiemermann C, et al. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci U S A 1994; 90: 11693–7

    Google Scholar 

  100. Polisson R. Nonsteroidal anti-inflammatory drugs: Practical and theoretical considerations in their selection. Am J Med 1996; 100 Suppl. 2A: 31S–6S

    PubMed  CAS  Google Scholar 

  101. Patrignani P, Panara MR, Greco A, et al. Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases. J Pharmacol Exp Ther 1994; 271: 1705–12

    PubMed  CAS  Google Scholar 

  102. Aronoff GR. Therapeutic implications associated with renal studies of nabumetone. J Rheumatol 1992; 19 Suppl. 36: 25–31

    Google Scholar 

  103. Hawker G. Prescribing nonsteroidal antiinflammatory drugs —whats new? J Rheumatol 1997; 24: 243–5

    PubMed  CAS  Google Scholar 

  104. Nowak J, Wenmalm A. Influence of indomethacin and of prostaglandin E1 on total and regional blood flow in man. Acta Physiol Scand 1978; 102: 484–91

    PubMed  CAS  Google Scholar 

  105. MacFarlane LL, Orak DJ, Simpson WM. NSAIDs, antihypertensive agents and loss of blood pressure control. Am Fam Physician 1995; 51: 849–56

    PubMed  CAS  Google Scholar 

  106. Haynes WG, Webb DJ. Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet 1994, 344: 852–4

    PubMed  CAS  Google Scholar 

  107. Ciabattoni G, Boss AH, Patrignani P, et al. Effects of sulindac on renal and extrarenal eicosanoid synthesis. Clin Pharmacol Ther 1987; 41: 380–3

    CAS  Google Scholar 

  108. Davis A, Day RO, Begg EJ. Interactions between non-steroidal anti-inflammatory drugs and antihypertensives and diuretics. Aust N Z J Med 1986; 16: 537–46

    PubMed  CAS  Google Scholar 

  109. Wing LM. NSAIDs —Interactions with antihypertensives and diuretics. In: Brooks P, Day RO, editors. Non-steroidal anti-inflammatory drugs. Basis for variability in response. Basel: Birkhauser Verlag; 1985: 91–7

    Google Scholar 

  110. Johnson AG, Seideman P, Day RO. Adverse drug interactions with nonsteroidal anti-inflammatory drugs: recognition, management and avoidance. Drug Saf 1993; 8(2): 99–127

    PubMed  CAS  Google Scholar 

  111. Champion GD. Therapeutic uses of the non-steroidal anti-inflammatory drugs. Med J Aust 1988; 149: 203–13

    PubMed  CAS  Google Scholar 

  112. Gibson T. Nonsteroidal anti-inflammatory drugs: another look. Br J Rheum 1988; 27: 87–90

    CAS  Google Scholar 

  113. Flynn BL. Rheumatoid arthritis and osteoarthritis: current and future therapies. Ann Pharm 1994; NS34: 31–9

    CAS  Google Scholar 

  114. Oates J. Antagonism of antihypertensive drug therapy by nonsteroidal anti-inflammatory drugs. Hypertens 1988; 11 Suppl. II: 114–6

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Pharmacology, The University of Queensland, Princess Alexandra Hospital, Brisbane, Queensland, 4102, Australia

    Anthony G. Johnson

Authors
  1. Anthony G. Johnson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Johnson, A.G. NSAIDs and Increased Blood Pressure. Drug-Safety 17, 277–289 (1997). https://doi.org/10.2165/00002018-199717050-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-199717050-00001

Keywords

Search

Navigation